These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4555421)

  • 1. Correlation between hydrolysis of the -lactam bond of the cephalosporin nucleus and expulsion of the 3-substituent.
    O'Callaghan CH; Kirby SM; Morris A; Waller RE; Duncombe RE
    J Bacteriol; 1972 Jun; 110(3):988-91. PubMed ID: 4555421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the substrate specificities of the -lactamases from Klebsiella aerogenes 1082E and Enterobacter cloacae P99.
    Marshall MJ; Ross GW; Chanter KV; Harris AM
    Appl Microbiol; 1972 Apr; 23(4):765-9. PubMed ID: 4553144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The purification and properties of a penicillinase whose synthesis is mediated by an R-factor in Escherichia coli.
    Datta N; Richmond MH
    Biochem J; 1966 Jan; 98(1):204-9. PubMed ID: 5328167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolysis of cephalosporins by beta-lactamases from gram-negative bacteria.
    Hamilton-Miller JM
    Nature; 1967 Jun; 214(5095):1333-4. PubMed ID: 4861905
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of inhibition of chromosomal beta-lactamases by third-generation cephalosporins.
    Charnas RL; Then RL
    Rev Infect Dis; 1988; 10(4):752-60. PubMed ID: 3142012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-lactamase insensitive or inhibitory beta-lactams: two approaches to the challenge of ampicillin-resistant E. coli.
    Richmond MH
    Scand J Infect Dis Suppl; 1978; (13):11-5. PubMed ID: 356180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between carbenicillin and beta-lactamases from Gram-negative bacteria.
    Bobrowski M; Borowski E
    J Gen Microbiol; 1971 Nov; 68(3):263-72. PubMed ID: 5002807
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of minimum inhibitory concentration and beta-lactamase activity.
    Ullmann U
    Infection; 1977; 5(4):261-2. PubMed ID: 340386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in proton-magnetic-resonance spectra during aminolysis and enzymic hydrolysis of cephalosporins.
    Hamilton-Miller JM; Richards E; Abraham EP
    Biochem J; 1970 Feb; 116(3):385-95. PubMed ID: 5435686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-turnover and steady-state kinetics of hydrolysis of cephalosporins by beta-lactamase I from Bacillus cereus.
    Bicknell R; Waley SG
    Biochem J; 1985 Oct; 231(1):83-8. PubMed ID: 3933490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterobacteria, beta-lactam antibiotics and beta-lactamases in clinical practice.
    Newsom SW; Marshall MJ; Harris AM
    J Med Microbiol; 1974 Nov; 7(4):473-82. PubMed ID: 4615152
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins.
    Labia R; Morand A; Tiwari K; Sirot J; Sirot D; Petit A
    Rev Infect Dis; 1988; 10(4):885-91. PubMed ID: 3055180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of beta-lactamases on QAE-sephadex.
    Ross GW; Boulton MG
    Biochim Biophys Acta; 1973 Jun; 309(2):430-9. PubMed ID: 4731970
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of methoxy-substitution of beta-lactam compounds on the interaction with various beta-lactamases.
    Cullmann W; Dick W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Nov; 256(1):109-18. PubMed ID: 6362278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.
    O'Callaghan CH; Morris A; Kirby SM; Shingler AH
    Antimicrob Agents Chemother; 1972 Apr; 1(4):283-8. PubMed ID: 4208895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of penicillins and cephalosporins to beta-lactamases assessed by a new test.
    Selwyn S
    J Antimicrob Chemother; 1977 Mar; 3(2):161-8. PubMed ID: 324965
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
    Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
    Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrolysis of third-generation cephalosporins by Enterobacter cloacae beta-lactamase.
    Cullmann W
    Eur J Clin Microbiol; 1985 Dec; 4(6):607-9. PubMed ID: 3879218
    [No Abstract]   [Full Text] [Related]  

  • 19. beta-Lactam susceptibility patterns and investigation of cephalosporin hydrolysing beta-lactamases of Gram-negative extraintestinal clinical isolates.
    Gál Z; Szabó D; Kovács P; Hernádi F; Tóth-Martinez B; Rozgonyi F
    Int J Antimicrob Agents; 2000 Dec; 16(4):395-400. PubMed ID: 11118847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate inhibition of beta-lactamases, a method for predicting enzymatic stability of cephalosporins.
    Mahoney DF; Koppel GA; Turner JR
    Antimicrob Agents Chemother; 1976 Sep; 10(3):470-5. PubMed ID: 984790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.